Global Pharma, Biotech and Diagnostics Distribution Partnering Deal Terms and Agreements Report/Directory 2021: Comprehensive Access to Available Records for Over 2,400 Distribution Deals
01 avr. 2022 04h23 HE
|
Research and Markets
Dublin, April 01, 2022 (GLOBE NEWSWIRE) -- The "Global Distribution Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2014 to 2021" report has been added to ResearchAndMarkets.com's...
Global Pharmacogenomics Services Market (2021 to 2031) - Focus on Service, Technology, Application, End-user and Country-Wise Analysis
24 janv. 2022 04h13 HE
|
Research and Markets
Dublin, Jan. 24, 2022 (GLOBE NEWSWIRE) -- The "Pharmacogenomics Services Market - A Global and Regional Analysis: Focus on Service, Technology, Application, End User, and Country-Wise Analysis -...
Inagene Diagnostics Inc. and Malo Smiles Canada team up to transform the experience of implant dentistry
24 nov. 2021 06h00 HE
|
Inagene Diagnostics Inc.
TORONTO, Nov. 24, 2021 (GLOBE NEWSWIRE) -- Leading dental implant centre Malo Smiles Toronto and genetic testing company Inagene Diagnostics Inc. are bringing innovation to dental care that will...
Inagene Diagnostics Inc. provides personalized medicine with genetic guidance to medical cannabis users
18 nov. 2021 06h00 HE
|
Inagene Diagnostics Inc.
TORONTO, Nov. 18, 2021 (GLOBE NEWSWIRE) -- Since cannabis legalization in 2018, interest in its medical application has been skyrocketing. Canadian consumers and health care providers seek guidance...
Inagene Diagnostics Inc. and The Newly Institute partner to optimize treatment for Canadians living with pain and/or mental health conditions
16 nov. 2021 06h00 HE
|
Inagene Diagnostics Inc.
TORONTO, Nov. 16, 2021 (GLOBE NEWSWIRE) -- Canadian pharmacogenetic (PGx) testing provider, Inagene Diagnostics Inc., has partnered with The Newly Institute, an advanced network of medically...
Inagene Diagnostics Inc. and Granville Biomedical Inc. team up to provide locally-produced pharmacogenetic testing kits to Canadians
01 nov. 2021 06h00 HE
|
Inagene Diagnostics Inc.
TORONTO, Nov. 01, 2021 (GLOBE NEWSWIRE) -- Canadian pharmacogenetic (PGx) testing provider, Inagene Diagnostics Inc., has partnered with fellow Canadian health-tech company, Granville Biomedical...
September’s International Pain Awareness Month marks critical moment to leverage more effective methods of treating chronic pain
26 août 2021 06h00 HE
|
Inagene Diagnostics Inc.
TORONTO, Aug. 26, 2021 (GLOBE NEWSWIRE) -- September marks Canada’s most important International Pain Awareness Month yet. The stressors brought on by the COVID-19 pandemic have manifested as new...
Inagene and Aspiria team up to improve mental health care for post-secondary students
16 août 2021 06h00 HE
|
Inagene Diagnostics Inc.
TORONTO, Aug. 16, 2021 (GLOBE NEWSWIRE) -- Canadian pharmacogenetic (PGx) testing provider, Inagene Diagnostics Inc., has partnered with Student Assistance Program provider Aspiria Corp., a CloudMD...
Global Gene Panel Market to Surpass US$ 29,975.8 Million by 2028, Says Coherent Market Insights (CMI)
02 août 2021 09h00 HE
|
CMI
SEATTLE, Aug. 02, 2021 (GLOBE NEWSWIRE) -- According to Coherent Market Insights, the global gene panel market is estimated to be valued at US$ 22,044.7 million in 2021 and is expected to exhibit a...
Canada’s surgery backlog could lead to wave of new chronic pain and opioid dependencies
21 juil. 2021 06h00 HE
|
Inagene Diagnostics Inc.
TORONTO, July 21, 2021 (GLOBE NEWSWIRE) -- As Canada’s vaccination rates climb and hospitals begin to tackle the mountain of postponed surgeries due to the pandemic, we are facing an echo epidemic...